institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published 3 hours ago • loading... • Updated 2 hours ago

AstraZeneca’s Cancer Drug Combo Hits Main Survival Goal in Late-Stage Trial

Summary by WTVB

Sept 8 (Reuters) - AstraZeneca said on ‌Tuesday its cancer ‌drug Imfinzi ⁠combined with ⁠Amgen's targeted immunotherapy Imdelltra significantly ⁠improved ⁠overall survival in first-line extensive-stage small ‌cell lung ⁠cancer in a ⁠late-stage ‌...

3 Articles

3 Articles

AstraZeneca’s cancer drug combo hits main survival goal in late-stage trial

Sept 8 (Reuters) - AstraZeneca said on ‌Tuesday its cancer ‌drug Imfinzi ⁠combined with ⁠Amgen's targeted immunotherapy Imdelltra significantly ⁠improved ⁠overall survival in first-line extensive-stage small ‌cell lung ⁠cancer in a ⁠late-stage ‌...

2 hours ago

Read Full Article

AstraZeneca's cancer drug combo hits main survival goal in late-stage trial

The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.

2 hours ago

Read Full Article

IMDELLTRA® IN COMBINATION WITH IMFINZI® DEMONSTRATED LANDMARK IMPROVEMENT IN OVERALL SURVIVAL IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER

3 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources3

Leaning Left0Leaning Right0Center1Last Updated2 hours agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news 3 hours ago on Tuesday, September 8, 2026.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics